According to Astec Lifesciences 's latest financial reports and stock price the company's current Operating Margin is 12.86%. At the end of 2022 the company had an Operating Margin of 17.90%.
Year | Operating Margin | Change |
---|---|---|
2022 | 17.90% | 11.53% |
2021 | 16.05% | 36.74% |
2020 | 11.74% | -9.51% |
2019 | 12.97% | -15.87% |
2018 | 15.42% | 60.24% |
2017 | 9.62% | -243.06% |
2016 | -6.73% | -194.48% |
2015 | 7.12% | 32.17% |
2014 | 5.39% | 8.14% |
2013 | 4.98% | 210.3% |
2012 | 1.61% | -74.77% |
2011 | 6.36% | -58.54% |
2010 | 15.35% | 4.34% |
2009 | 14.71% | -14.11% |
2008 | 17.12% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.